Skip to main content
Search result for "Solr search content"
Search Result for "*:*"
Story

Mays Cancer Center studies help spur leukemia drug’s approval

The FDA has approved pacritinib for myelofibrosis patients with low platelet counts. Investigators at the Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, played a lead role in gaining U.S. Food and Drug Administration approval of pacritinib to treat the chronic leukemia known as myelofibrosis. The FDA granted accelerated approval of the […]

Story

Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials

An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]

Mays Cancer Center Annual Research Symposium

Submitted by palaciosma on
Name
Primary address